BRAINSWAY LTD-ADR (BWAY) Stock Fundamental Analysis
NASDAQ:BWAY - Nasdaq - US10501L1061 - ADR - Currency: USD
Overall BWAY gets a fundamental rating of 6 out of 10. We evaluated BWAY against 187 industry peers in the Health Care Equipment & Supplies industry. While BWAY has a great health rating, its profitability is only average at the moment. BWAY has both an excellent growth and valuation score. This means it is growing and it is still cheap. This is a rare combination! These ratings could make BWAY a good candidate for value and growth investing.
1. Profitability
1.1 Basic Checks
BWAY had positive earnings in the past year.
In the past year BWAY had a positive cash flow from operations.
In the past 5 years BWAY reported 4 times negative net income.
In multiple years BWAY reported negative operating cash flow during the last 5 years.
1.2 Ratios
BWAY's Return On Assets of 3.91% is amongst the best of the industry. BWAY outperforms 80.75% of its industry peers.
BWAY's Return On Equity of 6.14% is amongst the best of the industry. BWAY outperforms 81.28% of its industry peers.
BWAY has a better Return On Invested Capital (1.90%) than 68.98% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.91% | ||
| ROE | 6.14% | ||
| ROIC | 1.9% |
ROA(3y)-8.09%
ROA(5y)-9.73%
ROE(3y)-11.6%
ROE(5y)-14.71%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
BWAY's Profit Margin of 9.01% is amongst the best of the industry. BWAY outperforms 82.89% of its industry peers.
BWAY has a Operating Margin of 4.32%. This is in the better half of the industry: BWAY outperforms 70.05% of its industry peers.
Looking at the Gross Margin, with a value of 74.51%, BWAY belongs to the top of the industry, outperforming 87.70% of the companies in the same industry.
BWAY's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.32% | ||
| PM (TTM) | 9.01% | ||
| GM | 74.51% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.39%
GM growth 5Y-0.85%
2. Health
2.1 Basic Checks
BWAY has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
BWAY has more shares outstanding than it did 1 year ago.
BWAY has more shares outstanding than it did 5 years ago.
BWAY has a worse debt/assets ratio than last year.
2.2 Solvency
BWAY has an Altman-Z score of 4.10. This indicates that BWAY is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of BWAY (4.10) is better than 74.33% of its industry peers.
The Debt to FCF ratio of BWAY is 0.69, which is an excellent value as it means it would take BWAY, only 0.69 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.69, BWAY belongs to the top of the industry, outperforming 92.51% of the companies in the same industry.
BWAY has a Debt/Equity ratio of 0.07. This is a healthy value indicating a solid balance between debt and equity.
BWAY has a Debt to Equity ratio of 0.07. This is in the better half of the industry: BWAY outperforms 61.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.07 | ||
| Debt/FCF | 0.69 | ||
| Altman-Z | 4.1 |
ROIC/WACC0.21
WACC9%
2.3 Liquidity
A Current Ratio of 5.03 indicates that BWAY has no problem at all paying its short term obligations.
BWAY has a better Current ratio (5.03) than 74.87% of its industry peers.
A Quick Ratio of 4.75 indicates that BWAY has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 4.75, BWAY is in the better half of the industry, outperforming 78.07% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.03 | ||
| Quick Ratio | 4.75 |
3. Growth
3.1 Past
BWAY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 268.04%, which is quite impressive.
BWAY shows a strong growth in Revenue. In the last year, the Revenue has grown by 26.86%.
The Revenue has been growing by 12.17% on average over the past years. This is quite good.
EPS 1Y (TTM)268.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)26.86%
Revenue growth 3Y11.41%
Revenue growth 5Y12.17%
Sales Q2Q%25.07%
3.2 Future
The Earnings Per Share is expected to grow by 23.62% on average over the next years. This is a very strong growth
BWAY is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 20.51% yearly.
EPS Next Y32.06%
EPS Next 2Y23.62%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year19.2%
Revenue Next 2Y20.51%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 12.08 indicates a correct valuation of BWAY.
Based on the Price/Earnings ratio, BWAY is valued cheaply inside the industry as 91.98% of the companies are valued more expensively.
BWAY is valuated cheaply when we compare the Price/Earnings ratio to 27.15, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 9.84, which indicates a very decent valuation of BWAY.
Based on the Price/Forward Earnings ratio, BWAY is valued cheaper than 93.58% of the companies in the same industry.
BWAY's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.60.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.08 | ||
| Fwd PE | 9.84 |
4.2 Price Multiples
BWAY's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. BWAY is cheaper than 67.38% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, BWAY is valued cheaply inside the industry as 81.82% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 30.76 | ||
| EV/EBITDA | 48.96 |
4.3 Compensation for Growth
BWAY's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as BWAY's earnings are expected to grow with 23.62% in the coming years.
PEG (NY)0.38
PEG (5Y)N/A
EPS Next 2Y23.62%
EPS Next 3YN/A
5. Dividend
5.1 Amount
BWAY does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:BWAY (7/1/2025, 12:55:49 PM)
13.05
-0.1 (-0.76%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners5.19%
Inst Owner Change1.22%
Ins Owners16.69%
Ins Owner ChangeN/A
Market Cap246.43M
Analysts85.71
Price Target0.08 (-99.39%)
Short Float %0.8%
Short Ratio3.09
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)35.29%
Min EPS beat(2)-22.64%
Max EPS beat(2)93.23%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-1.17%
Min Revenue beat(2)-2.35%
Max Revenue beat(2)0.01%
Revenue beat(4)3
Avg Revenue beat(4)-0.34%
Min Revenue beat(4)-2.35%
Max Revenue beat(4)0.82%
Revenue beat(8)6
Avg Revenue beat(8)1.7%
Revenue beat(12)6
Avg Revenue beat(12)-23.98%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.45%
PT rev (3m)-0.75%
EPS NQ rev (1m)0%
EPS NQ rev (3m)14.06%
EPS NY rev (1m)0%
EPS NY rev (3m)65.43%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.43%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.42%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.08 | ||
| Fwd PE | 9.84 | ||
| P/S | 5.67 | ||
| P/FCF | 30.76 | ||
| P/OCF | 20.32 | ||
| P/B | 3.87 | ||
| P/tB | 3.87 | ||
| EV/EBITDA | 48.96 |
EPS(TTM)1.08
EY8.28%
EPS(NY)1.33
Fwd EY10.16%
FCF(TTM)0.42
FCFY3.25%
OCF(TTM)0.64
OCFY4.92%
SpS2.3
BVpS3.38
TBVpS3.38
PEG (NY)0.38
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.91% | ||
| ROE | 6.14% | ||
| ROCE | 2.25% | ||
| ROIC | 1.9% | ||
| ROICexc | 13.5% | ||
| ROICexgc | 13.5% | ||
| OM | 4.32% | ||
| PM (TTM) | 9.01% | ||
| GM | 74.51% | ||
| FCFM | 18.43% |
ROA(3y)-8.09%
ROA(5y)-9.73%
ROE(3y)-11.6%
ROE(5y)-14.71%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.39%
GM growth 5Y-0.85%
F-Score6
Asset Turnover0.43
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.07 | ||
| Debt/FCF | 0.69 | ||
| Debt/EBITDA | 1.28 | ||
| Cap/Depr | 223.14% | ||
| Cap/Sales | 9.47% | ||
| Interest Coverage | 8.86 | ||
| Cash Conversion | 325.76% | ||
| Profit Quality | 204.52% | ||
| Current Ratio | 5.03 | ||
| Quick Ratio | 4.75 | ||
| Altman-Z | 4.1 |
F-Score6
WACC9%
ROIC/WACC0.21
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)268.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y32.06%
EPS Next 2Y23.62%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)26.86%
Revenue growth 3Y11.41%
Revenue growth 5Y12.17%
Sales Q2Q%25.07%
Revenue Next Year19.2%
Revenue Next 2Y20.51%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y256.63%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-6.6%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y177.7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y217.63%
OCF growth 3Y127.03%
OCF growth 5YN/A